Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Eloah Rabello Suarez"'
Autor:
Erik Montagna, Najla Santos Pacheco de Campos, Victoria Alves Porto, Giselle Correia Próspero da Silva, Eloah Rabello Suarez
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract CD19-targeted chimeric antigen receptors (CAR) T cells are one of the most remarkable cellular therapies for managing B cell malignancies. However, long-term disease-free survival is still a challenge to overcome. Here, we evaluated the infl
Externí odkaz:
https://doaj.org/article/ea69cd6a29524f8e9bedfb521d4b0ff4
Autor:
Yufei Wang, Eloah Rabello Suarez, Gabriella Kastrunes, Najla Santos Pacheco de Campos, Rabia Abbas, Renata Schmieder Pivetta, Nithyassree Murugan, Ghanbar Mahmoodi Chalbatani, Vincent D’Andrea, Wayne A. Marasco
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-21 (2024)
Abstract Treatment for renal cell carcinoma (RCC) has improved dramatically over the last decade, shifting from high-dose cytokine therapy in combination with surgical resection of tumors to targeted therapy, immunotherapy, and combination therapies.
Externí odkaz:
https://doaj.org/article/739362afabd24506afe9b7a84c657831
Autor:
Hassan Dana, Ghanbar Mahmoodi Chalbatani, Seyed Amir Jalali, Hamid Reza Mirzaei, Stephan A. Grupp, Eloah Rabello Suarez, Catarina Rapôso, Thomas J. Webster
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 5, Pp 1129-1147 (2021)
New approaches to cancer immunotherapy have been developed, showing the ability to harness the immune system to treat and eliminate cancer. For many solid tumors, therapy with checkpoint inhibitors has shown promise. For hematologic malignancies, ado
Externí odkaz:
https://doaj.org/article/467f6f3d26334a5997a6c084ab98d385
Autor:
Leandro Luongo Matos, Eloah Rabello Suarez, Thérèse Rachell Theodoro, Damila Cristina Trufelli, Carina Mucciolo Melo, Larissa Ferraz Garcia, Olivia Capela Grimaldi Oliveira, Maria Graciela Luongo Matos, Jossi Ledo Kanda, Helena Bonciani Nader, João Roberto Maciel Martins, Maria Aparecida Silva Pinhal
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141139 (2015)
The search for a specific marker that could help to distinguish between differentiated thyroid carcinoma and benign lesions remains elusive in clinical practice. Heparanase (HPSE) is an endo-beta-glucoronidase implicated in the process of tumor invas
Externí odkaz:
https://doaj.org/article/ac960fdc2c8b40029d33c9cd13e8771c
Autor:
Carina Mucciolo Melo, Clarice Silvia Taemi Origassa, Thérèse Rachell Theodoro, Leandro Luongo Matos, Thaís Aguilar Miranda, Camila Melo Accardo, Rodrigo Ippolito Bouças, Eloah Rabello Suarez, Madalena Maria Nunes Silva Pares, Daniel Reis Waisberg, Giovanna Canato Toloi, Helena Bonciani Nader, Jaques Waisberg, Maria Aparecida Silva Pinhal
Publikováno v:
São Paulo Medical Journal, Vol 133, Iss 1, Pp 28-35
CONTEXT AND OBJECTIVE: Heparanase-1 degrades heparan sulfate and has been correlated with tumor progression. Although the isoform heparanase-2 has no catalytic activity, it seems to be important for modulating heparanase-1 activity. Cathepsin B is a
Externí odkaz:
https://doaj.org/article/25df9f0126ac4d3b9b3b1fed3b7a0e9f
Autor:
Giovani Bravin Peres, Adriana Taveira da Cruz Peres, Najla dos Santos Pacheco de Campos, Eloah Rabello Suarez
Publikováno v:
Handbook of Cancer and Immunology ISBN: 9783030809621
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48dc4aeebcd37c2d982c427d316f84c2
https://doi.org/10.1007/978-3-030-80962-1_53-1
https://doi.org/10.1007/978-3-030-80962-1_53-1
Autor:
Catarina Rapôso, Hassan Dana, Eloah Rabello Suarez, Stephan A. Grupp, Ghanbar Mahmoodi Chalbatani, Thomas J. Webster, Hamid Reza Mirzaei, Seyed Amir Jalali
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 11, Iss 5, Pp 1129-1147 (2021)
Acta Pharmaceutica Sinica B, Vol 11, Iss 5, Pp 1129-1147 (2021)
New approaches to cancer immunotherapy have been developed, showing the ability to harness the immune system to treat and eliminate cancer. For many solid tumors, therapy with checkpoint inhibitors has shown promise. For hematologic malignancies, ado
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68bfcde6c0433440428fd30c520684a5
https://doi.org/10.1016/j.apsb.2020.10.020
https://doi.org/10.1016/j.apsb.2020.10.020
Autor:
Najla Santos Pacheco de Campos, Adriano de Oliveira Beserra, Pedro Henrique Barbosa Pereira, Alexandre Silva Chaves, Fernando Luiz Affonso Fonseca, Tiago da Silva Medina, Tiago Goss dos Santos, Yufei Wang, Wayne Anthony Marasco, Eloah Rabello Suarez
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 10; Pages: 5448
The complete regression of clear cell renal cell carcinoma (ccRCC) obtained pre-clinically with anti-carbonic anhydrase IX (CAIX) G36 chimeric antigen receptor (CAR) T cells in doses equivalent to ≅108 CAR T cells/kg renewed the potential of this t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212cf0044f1fa9b0b77b0994d9048ab2
https://pubmed.ncbi.nlm.nih.gov/35628256
https://pubmed.ncbi.nlm.nih.gov/35628256
Autor:
Najla Santos Pacheco de Campos, Bruna Santos Souza, Giselle Correia Próspero da Silva, Victoria Alves Porto, Ghanbar Mahmoodi Chalbatani, Gabriela Lagreca, Bassam Janji, Eloah Rabello Suarez
Publikováno v:
Cancers. 14(6)
The carbonic anhydrase isoform IX (CAIX) enzyme is constitutively overexpressed in the vast majority of clear cell renal cell carcinoma (ccRCC) and can also be induced in hypoxic microenvironments, a major hallmark of most solid tumors. CAIX expressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28e9d9ceed0b8774b7f24d922cd173fa
https://pubmed.ncbi.nlm.nih.gov/35326544
https://pubmed.ncbi.nlm.nih.gov/35326544
Autor:
Ming, Zhong, Ghanbar Mahmoodi, Chalbatani, Meifang, Deng, Qiuyi, Li, Elahe, Gharagouzloo, Michael R, Hamblin, Eloah Rabello, Suarez, Lili, Hu, Dingding, Wang
Publikováno v:
European Journal of Pharmaceutical Sciences. 180:106331
CAR-T cell therapy, in which T cells are transfected or transduced with a chimeric antigen receptor (CAR), is a transformative type of cancer immunotherapy. Despite outstanding success in hematological malignancies, their efficacy against solid tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc4f48bba3e32b6ff2e42b23d4e5cf05
https://doi.org/10.1016/j.ejps.2022.106331
https://doi.org/10.1016/j.ejps.2022.106331